T
Thomas W. Hoffmann
Researcher at Institut national de la recherche agronomique
Publications - 9
Citations - 1455
Thomas W. Hoffmann is an academic researcher from Institut national de la recherche agronomique. The author has contributed to research in topics: Gut flora & Microbiome. The author has an hindex of 6, co-authored 8 publications receiving 983 citations. Previous affiliations of Thomas W. Hoffmann include Agro ParisTech & Université Paris-Saclay.
Papers
More filters
Journal ArticleDOI
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands
Bruno Lamas,Mathias L. Richard,Valentin Leducq,Hang-Phuong Pham,Marie-Laure Michel,Grégory Da Costa,Chantal Bridonneau,Sarah Jegou,Thomas W. Hoffmann,Jane M. Natividad,Loic Brot,Soraya Taleb,Soraya Taleb,Aurélie Couturier-Maillard,Isabelle Nion-Larmurier,Fatiha Merabtene,Philippe Seksik,Anne Bourrier,Jacques Cosnes,Bernhard Ryffel,Bernhard Ryffel,Laurent Beaugerie,Jean-Marie Launay,Philippe Langella,Ramnik J. Xavier,Harry Sokol +25 more
TL;DR: In this article, a relationship between the host and the gut microbiota govern intestinal homeostasis is revealed, and the authors reveal that host genes affect the composition and function of the Gut microbiota, altering the production of microbial metabolites and intestinal inflammation.
Journal ArticleDOI
Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients
Giuseppina Liguori,Bruno Lamas,Mathias L. Richard,Mathias L. Richard,Giovanni Brandi,Grégory Da Costa,Grégory Da Costa,Thomas W. Hoffmann,Thomas W. Hoffmann,Massimo Pierluigi Di Simone,Carlo Calabrese,Gilberto Poggioli,Philippe Langella,Philippe Langella,Massimo Campieri,Harry Sokol +15 more
TL;DR: This study confirms the alteration of the bacterial microbiota and is the first demonstration of the existence of an altered fungal microbiota in Crohn's disease patients, suggesting that fungi may play a role in pathogenesis.
Journal ArticleDOI
Mucosa-associated microbiota dysbiosis in colitis associated cancer.
Mathias L. Richard,Giuseppina Liguori,Bruno Lamas,Giovanni Brandi,Grégory Da Costa,Thomas W. Hoffmann,Massimo Pierluigi Di Simone,Carlo Calabrese,Gilberto Poggioli,Philippe Langella,Massimo Campieri,Harry Sokol +11 more
TL;DR: This study confirms the alteration of the mucosa-associated bacterial microbiota in IBD and SC, and is the first evidence of the existence of an alteredacterial microbiota in CAC clearly different from the one in SC patients.
Journal ArticleDOI
Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.
Thomas W. Hoffmann,Thomas W. Hoffmann,Hang-Phuong Pham,Chantal Bridonneau,Chantal Bridonneau,Camille Aubry,Camille Aubry,Bruno Lamas,Camille Martin-Gallausiaux,Camille Martin-Gallausiaux,Marco Moroldo,Marco Moroldo,Dominique Rainteau,Nicolas Lapaque,Nicolas Lapaque,Adrien Six,Mathias L. Richard,Mathias L. Richard,Emilie Fargier,Marie-Emmanuelle Le Guern,Philippe Langella,Philippe Langella,Harry Sokol +22 more
TL;DR: Analysis of host–microbiota interactions in mice that were mono-associated with six microorganisms that are representative of inflammatory bowel disease (IBD)-associated dysbiosis reveals that microorganisms with a potential role in intestinal homeostasis and inflammation have specific impacts on the host, and suggests several tracks to follow to understand intestinal homestasis and IBD pathogenesis better.
Journal ArticleDOI
Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease
Mathias L. Richard,Mathias L. Richard,Bruno Lamas,Giuseppina Liguori,Thomas W. Hoffmann,Thomas W. Hoffmann,Harry Sokol +6 more
TL;DR: Understanding of the fungal microbiota composition and its impact on IBD has greatly increased in the past 8 years and special attention was paid to the various effects of this microbial community on the IBD, i.e., the mechanisms and immune pathways involved in these interactions.